Rafael Holdings, Inc. (NYSE:RFL – Get Free Report) was the target of a large increase in short interest in February. As of February 27th, there was short interest totaling 55,181 shares, an increase of 43.5% from the February 12th total of 38,452 shares. Based on an average trading volume of 54,408 shares, the short-interest ratio is currently 1.0 days. Approximately 0.2% of the company’s stock are sold short. Approximately 0.2% of the company’s stock are sold short. Based on an average trading volume of 54,408 shares, the short-interest ratio is currently 1.0 days.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Rafael in a report on Monday, December 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.
Check Out Our Latest Stock Analysis on Rafael
Institutional Inflows and Outflows
Rafael Stock Performance
NYSE:RFL opened at $1.31 on Monday. The company has a market capitalization of $67.56 million, a P/E ratio of -1.54 and a beta of 0.58. The stock’s 50 day moving average price is $1.28 and its 200 day moving average price is $1.31. Rafael has a 52 week low of $1.12 and a 52 week high of $3.19.
Rafael Company Profile
Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.
Further Reading
- Five stocks we like better than Rafael
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Rafael Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rafael and related companies with MarketBeat.com's FREE daily email newsletter.
